Lipid profiling of pre-treatment plasma reveals biomarker candidates associated with response rates and hand-foot skin reactions in sorafenib-treated patients.
Cancer Chemother Pharmacol
; 82(4): 677-684, 2018 10.
Article
en En
| MEDLINE
| ID: mdl-30062555
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Carcinoma Hepatocelular
/
Síndrome Mano-Pie
/
Sorafenib
/
Lípidos
/
Neoplasias Hepáticas
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Cancer Chemother Pharmacol
Año:
2018
Tipo del documento:
Article
País de afiliación:
Japón